EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1‐year double‐blinded placebo‐controlled randomized clinical trial

Marcelo Faveri, Belen Retamal-Valdes iD, Maria Josefa Mestnik, Luciene Cristina de Figueiredo, Valentim Adelino Ricardo Barão iD, João Gabriel Silva Souza iD, Poliana Mendes Duarte iD, Magda Feres

Journal of Periodontology · 2023

DOI: 10.1002/jper.21-0171 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontology, 2023. Verfasst von Marcelo Faveri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil. Hauptthemen laut MEDLINE: Dental Plaque, Periodontitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the body of evidence supporting the clinical benefits of metronidazole (MTZ) and amoxicillin (AMX) in the treatment of young patients with periodontitis, the microbiological outcomes of this antibiotic protocol have been less explored. This study evaluated the microbiological effects of adjunctive MTZ+AMX in the treatment of young patients with periodontitis.

Methods

Subjects with periodontitis Stages III or IV and ≤30 years old were randomly allocated to receive scaling and root planing (SRP) with placebo ( n = 15) or with MTZ (400 mg) and AMX (500 mg) three times a day for 14 days ( n = 15). Nine subgingival biofilm samples per subject (three samples from each probing depth (PD) category: ≤3, 4–6, and ≥7 mm) were collected at baseline and 3‐, 6‐, and 12‐months post‐treatment and individually analyzed for 40 bacterial species by checkerboard DNA–DNA hybridization.

Results

Thirty subjects (15/group) with mean ages 27.6 ± 3.5 (control) and 26.8 ± 3.9 (test) were included. At 12 months post‐therapy, the antibiotic group harbored lower proportions of red complex (1.3%) than the placebo group (12.5%) ( p < 0.05). SRP + MTZ+AMX was more effective than mechanical treatment in reducing levels/proportions of several pathogens and increasing proportions of Actinomyces species ( p < 0.05). Levels/proportions of Aggregatibacter actinomycetemcomitans were only reduced in the antibiotic group ( p < 0.05). This group also exhibited greater reduction in the number of sites with PD ≥5 mm and higher percentage of subjects reaching the clinical end point for treatment (≤4 sites with PD ≥5 mm) than the control group ( p < 0.05).

Conclusion

SRP+MTZ+AMX allowed for establishing a long‐term healthier subgingival biofilm community and periodontal clinical condition, than SRP only.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dental PlaquePeriodontitisHumansYoung AdultAdultMetronidazoleAmoxicillinCombined Modality TherapyAnti-Bacterial AgentsDental ScalingRoot PlaningDNATreatment Outcome

Stichwörter der Autor:innen

amoxicillindental scalingmetronidazolemicrobiologyperiodontitisroot planingyoung adult

Substanzen

MetronidazoleAmoxicillinAnti-Bacterial AgentsDNA

Autor:innen und Institutionen

  • Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.
  • Department of Prosthodontics and Periodontology, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil.
  • Dental Science School (Faculdade de Ciências Odontológicas-FCO), Montes, Claros, Brazil.
  • Department of Periodontology, University of Florida College of Dentistry, Gainesville, Florida, USA.
  • The Forsyth Institute, Cambridge, Massachusetts, USA.

ORCID-Profile: Belen Retamal-Valdes, Valentim Adelino Ricardo Barão, João Gabriel Silva Souza, Poliana Mendes Duarte

Zitieren

APA

Faveri, M., Retamal-Valdes, B., Mestnik, M. J., de Figueiredo, L. C., Barão, V. A. R., Souza, J. G. S., Duarte, P. M., & Feres, M. (2023). Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1‐year double‐blinded placebo‐controlled randomized clinical trial. Journal of Periodontology. https://doi.org/10.1002/jper.21-0171

Vancouver

Faveri M, Retamal-Valdes B, Mestnik MJ, de Figueiredo LC, Barão VAR, Souza JGS, et al. Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1‐year double‐blinded placebo‐controlled randomized clinical trial. Journal of Periodontology. 2023. doi:10.1002/jper.21-0171

BibTeX
@article{Faveri2023,
  author = {Faveri, Marcelo and Retamal-Valdes, Belen and Mestnik, Maria Josefa and de Figueiredo, Luciene Cristina and Barão, Valentim Adelino Ricardo and Souza, João Gabriel Silva and Duarte, Poliana Mendes and Feres, Magda},
  title = {Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1‐year double‐blinded placebo‐controlled randomized clinical trial},
  journal = {Journal of Periodontology},
  year = {2023},
  doi = {10.1002/jper.21-0171}
}
Kostenlos starten →